AhmadHalwaniMD

Oncology • Salt Lake City, UT

Cutaneous Lymphoma, Hematologic Oncology

Physician

Join to view full profile

Dr. Halwani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Halwani's full profile

Already have an account?

Office
N Medical Dr
# 50
Salt Lake City, UT 84132
Phone+1 801-581-7907

Fax+1 801-581-5393

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Allergy and Immunology, 2007 - 2009
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2004 - 2007
American University of Beirut Faculty of MedicineClass of 2003

Certifications & Licensure

UT State Medical License 2011 - 2026
IA State Medical License 2004 - 2011
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

39 citations
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai, Jeffrey A. Barnes, Stefan K. Barta
Journal of the National Comprehensive Cancer Network. 2018-02-01
2664 citations
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C. Scott
The New England Journal of Medicine. 2015-01-21
2 citations
Maintenance rituximab in Veterans with follicular lymphoma
Ahmad Halwani, Kelli M Rasmussen, Vikas Patil, Deborah Morreall, Catherine Li
Cancer Medicine. 2020-08-28

Abstracts/Posters

Discontinuation Patterns in Patients Receiving Novel Oral Agents for Chronic Lymphocytic Leukemia in the Veterans Health Administration
Ahmad S Halwani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Survival Patterns in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: Treatment Trajectories and Responses after the First Relapse
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

Research Highlights for February 2023March 7th, 2023
Analysis Finds First-Line Practice Patterns in WM Have Shifted Significantly Since 2006December 5th, 2020
NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)November 7th, 2018
Join now to see all